ONS CHEMOTHERAPY
IMMUNOTHERAPY CERTIFICATE
3opmajoropphasesopofopcellopdivision:op-opans--Interphase
Mitoticopphase
Cytokinesis
3opstepsopofopinterphase:op-opans--Firstopgrowthopphaseop(G1)
Synthesisopphaseop(Sopphase)
Secondopgrowthopphaseop(G2)
4opphasesopofopmitosis:op-opans--Prophase
Metaphase
Anaphase
Telophase
Innateopimmunity:op-opans--Non-specificopresponse,opeither:
1.opBarrierop(skin,opmucousopmembranes,opfloraopofopskin/gut)
2.opCellularopcomponentsop(phagocytes,opnaturalopkilleropcells,opgranulocytes,opmacroph
ages)
Adaptiveopimmunity:op-opans--
Followsopinnateopimmunityopifopunsuccessful.opMemoryopimmunity,opincluding:
1.opHumoralopimmunityop(productionopofopantibodiesoporopimmunoglobulins)
2.opCellopmediatedopimmunityop(dependentopuponopTopcells)
3.opRegulatoryopTop-
cellsop(preventopautoimmuneopreactionsopandoplimitopinflammatoryopresponses)
Defineopmutationsop-opans--Variationsopinoptheopnucleotideopsequenceopofopaopgene
3opmainopgoalsopofoptreatment:op-opans--Cure
Control
Palliation
Defineopneoadjuvantoptherapyop-opans--
Treatmentopisopgivenopprioroptoopsurgeryoptoopshrinkoptheoptumor
, Defineopadjuvantoptherapyop-opans--
Additionalopcanceroptreatmentopgivenopafteroptheopprimaryoptreatmentoptooploweroptheopris
kopthatoptheopcanceropreoccur
Defineopconditioning/preparativeoptherapyop-opans--
Treatmentsopusedoptoopprepareopaoppatientopforopstemopcelloptransplantation
2optypesopofopconditioningoptherapies:op-opans--Myeloablative
Nonmyeloablative
Defineopdoseopdensityop-opans--Drugopdoseopperopunitopofoptime
Defineopdoseopintensityop-opans--Amountopofopdrugopdeliveredopoveroptime
Howopisoprelativeopdoseopintensityop(RDI)opcalculated?op-opans--
ByopcomparingoptheopdoseopthatoptheoppatientopACTUALLYopreceivedoptooptheopplannedo
pdoseopofoptheopstandardopregimen
Howopdoopalkylatingopagentsopwork?op-opans--
ByopcausingopaopbreakopinoptheopDNAophelixopstrand,opinterferingopwithopDNAopreplication
opandopcausingopcellopdeath
3opsubcategoriesopofopalkylatingopagents:op-opans--1.opNitrogenopmustards
2.opPlatinum-
basedopagentsop(doopnotoppossessopanopalkylopgroupopbutopstilloptermedopalkylatingopage
ntsopasoptheyopworkopsimilarly)
3.opNitrosoureas
Mostopcommonopsubcategoryopofopalkylatingopagents:op-opans--Nitrogenopmustards
Commonopalkylatingopagents:op-opans--Cyclophosphamideop(Cytoxan)
Ifosfamideop(Ifex)
Bendamustineop(Treanda)
Commonopplatinum-basedopagents:op-opans--Cisplatinop(Platinol)
Carboplatinop(Paraplatin)
Whatopisopuniqueopaboutopnitrosoureasopagents?op-opans--Ableoptoopcrossoptheopblood-
brainopbarrier;opcanopbeopeffectiveopinoptreatingopsomeopbrainoptumors
Commonopnitrosoureasopagents:op-opans--Carmustineop(BiCNU)
Lomustineop(CeeNu)
Streptozocinop(Zanosar)
Hypersensitivityopcanopoccuropwithoplateopdosesopof:op-opans--Carboplatin
IMMUNOTHERAPY CERTIFICATE
3opmajoropphasesopofopcellopdivision:op-opans--Interphase
Mitoticopphase
Cytokinesis
3opstepsopofopinterphase:op-opans--Firstopgrowthopphaseop(G1)
Synthesisopphaseop(Sopphase)
Secondopgrowthopphaseop(G2)
4opphasesopofopmitosis:op-opans--Prophase
Metaphase
Anaphase
Telophase
Innateopimmunity:op-opans--Non-specificopresponse,opeither:
1.opBarrierop(skin,opmucousopmembranes,opfloraopofopskin/gut)
2.opCellularopcomponentsop(phagocytes,opnaturalopkilleropcells,opgranulocytes,opmacroph
ages)
Adaptiveopimmunity:op-opans--
Followsopinnateopimmunityopifopunsuccessful.opMemoryopimmunity,opincluding:
1.opHumoralopimmunityop(productionopofopantibodiesoporopimmunoglobulins)
2.opCellopmediatedopimmunityop(dependentopuponopTopcells)
3.opRegulatoryopTop-
cellsop(preventopautoimmuneopreactionsopandoplimitopinflammatoryopresponses)
Defineopmutationsop-opans--Variationsopinoptheopnucleotideopsequenceopofopaopgene
3opmainopgoalsopofoptreatment:op-opans--Cure
Control
Palliation
Defineopneoadjuvantoptherapyop-opans--
Treatmentopisopgivenopprioroptoopsurgeryoptoopshrinkoptheoptumor
, Defineopadjuvantoptherapyop-opans--
Additionalopcanceroptreatmentopgivenopafteroptheopprimaryoptreatmentoptooploweroptheopris
kopthatoptheopcanceropreoccur
Defineopconditioning/preparativeoptherapyop-opans--
Treatmentsopusedoptoopprepareopaoppatientopforopstemopcelloptransplantation
2optypesopofopconditioningoptherapies:op-opans--Myeloablative
Nonmyeloablative
Defineopdoseopdensityop-opans--Drugopdoseopperopunitopofoptime
Defineopdoseopintensityop-opans--Amountopofopdrugopdeliveredopoveroptime
Howopisoprelativeopdoseopintensityop(RDI)opcalculated?op-opans--
ByopcomparingoptheopdoseopthatoptheoppatientopACTUALLYopreceivedoptooptheopplannedo
pdoseopofoptheopstandardopregimen
Howopdoopalkylatingopagentsopwork?op-opans--
ByopcausingopaopbreakopinoptheopDNAophelixopstrand,opinterferingopwithopDNAopreplication
opandopcausingopcellopdeath
3opsubcategoriesopofopalkylatingopagents:op-opans--1.opNitrogenopmustards
2.opPlatinum-
basedopagentsop(doopnotoppossessopanopalkylopgroupopbutopstilloptermedopalkylatingopage
ntsopasoptheyopworkopsimilarly)
3.opNitrosoureas
Mostopcommonopsubcategoryopofopalkylatingopagents:op-opans--Nitrogenopmustards
Commonopalkylatingopagents:op-opans--Cyclophosphamideop(Cytoxan)
Ifosfamideop(Ifex)
Bendamustineop(Treanda)
Commonopplatinum-basedopagents:op-opans--Cisplatinop(Platinol)
Carboplatinop(Paraplatin)
Whatopisopuniqueopaboutopnitrosoureasopagents?op-opans--Ableoptoopcrossoptheopblood-
brainopbarrier;opcanopbeopeffectiveopinoptreatingopsomeopbrainoptumors
Commonopnitrosoureasopagents:op-opans--Carmustineop(BiCNU)
Lomustineop(CeeNu)
Streptozocinop(Zanosar)
Hypersensitivityopcanopoccuropwithoplateopdosesopof:op-opans--Carboplatin